本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioCryst制药

8.07
-0.2900-3.47%
盘后:8.440.3699+4.58%17:07 EDT
成交量:303.93万
成交额:2,481.29万
市值:20.62亿
市盈率:-5.36
高:8.32
开:8.22
低:8.06
收:8.36
52周最高:11.22
52周最低:6.00
股本:2.56亿
流通股本:2.22亿
量比:0.76
换手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):-1.5054
每股收益(LYR):1.21
净资产收益率:587.33%
总资产收益率:52.86%
市净率:-4.54
市盈率(LYR):6.67

数据加载中...

2020/02/25

重要事件披露

Current report, items 5.02 and 9.01
2020/02/18

重要事件披露

Current report, items 8.01 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

重要事件披露

Current report, items 8.01 and 9.01
2020/01/22

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

重要事件披露

Current report, items 8.01 and 9.01
2020/01/13

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/12/11

重要事件披露

Current report, items 8.01 and 9.01
2019/11/21

重要事件披露

Current report, items 1.01 and 9.01
2019/11/20

重要事件披露

Current report, items 1.01 and 9.01
2019/11/19

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/18

重要事件披露

Current report, items 8.01 and 9.01
2019/11/08

季度报告

Quarterly report [Sections 13 or 15(d)]